US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Eikon Therapeutics

14.90

+0.43002.97%

Post-market: 14.900.00000.00%16:28 EST

Volume:336.04K

Turnover:5.00M

Market Cap:804.37M

PE:- -

High:15.23

Open:14.23

Low:14.21

Close:14.47

52wk High:17.40

52wk Low:13.29

Shares:53.98M

Float Shares:17.65M

Volume Ratio:0.72

T/O Rate:1.90%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:-1.00

PE(LYR):- -

Loading ...

Overview Company News Filings

Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO

Wall Street Braces For IPO Boom: Goldman Says 2026 Listings Could Hit $160 Billion As Tech, AI Lead

Benzinga_recent_news

Insiders Quietly Load Up on Eikon Therapeutics in Multi-Million Dollar Buying Spree

Eikon Therapeutics completes IPO and updates governance documents

Eikon Therapeutics Shares Fall in Nasdaq Debut

MT Newswires Live

Stock Track | Eikon Therapeutics Plummets 7.5% Intraday as Stock Debuts Below IPO Price

Eikon Therapeutics Debuts on Nasdaq with Over 5% Opening Decline

Eikon Therapeutics valued at $860 million in Nasdaq debut

Eikon Therapeutics indicated to open at $17.92, IPO priced at $18 per share

Eikon Therapeutics Sets IPO Price at $18 Per Share, Raising $381.2 Million Ahead of Nasdaq Debut

Perlmutter-backed Eikon Therapeutics raises $381.2 million in IPO

Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering

Merck Expected to Buy $30 Million Stake in Eikon Therapeutics' IPO, Bloomberg Reports

MT Newswires Live

Merck Veteran Executives Lead Cancer Drug Developer Eikon Therapeutics (EIKN.US) in US IPO Push

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EIKN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EIKN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EIKN\",,,,,undefined,":{"symbol":"EIKN","market":"US","secType":"STK","nameCN":"Eikon Therapeutics","latestPrice":14.9,"timestamp":1771966800000,"preClose":14.47,"halted":0,"volume":336038,"hourTrading":{"tag":"盘后","latestPrice":14.9,"preClose":14.9,"latestTime":"16:28 EST","volume":741,"amount":11040.9,"timestamp":1771968485415,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.029716655148583255,"floatShares":17648000,"shares":53984300,"eps":0,"marketStatus":"Not Yet Opened","change":0.43,"latestTime":"02-24 16:00:00 EST","open":14.23,"high":15.23,"low":14.21,"amount":4998840.405,"amplitude":0.070491,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772010000000},"marketStatusCode":0,"adr":0,"listingDate":1770267600000,"exchange":"NASDAQ","adjPreClose":14.47,"preHourTrading":{"tag":"盘前","latestPrice":14.2,"preClose":14.47,"latestTime":"08:41 EST","volume":412,"amount":6031.151404,"timestamp":1771940508234,"change":-0.27,"changeRate":-0.018659,"amplitude":0.226676},"postHourTrading":{"tag":"盘后","latestPrice":14.9,"preClose":14.9,"latestTime":"16:28 EST","volume":741,"amount":11040.9,"timestamp":1771968485415,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.721703},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EIKN\",,,,,undefined,":{"symbol":"EIKN","floatShares":17648000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.721703,"shares":53984300,"dividePrice":0,"high":15.23,"amplitude":0.070491,"preClose":14.47,"low":14.21,"week52Low":13.285,"pbRate":"-1.00","week52High":17.4,"institutionHeld":0,"latestPrice":14.9,"eps":0,"divideRate":0,"volume":336038,"delay":0,"ttmEps":0,"open":14.23,"prevYearClose":18,"prevWeekClose":14.88,"prevMonthClose":18,"prevQuarterClose":18,"fiveDayClose":15.72,"twentyDayClose":18,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EIKN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EIKN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EIKN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EIKN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EIKN","date":"2026-02-23","current":-2.595292,"percent":0.545455,"low":-3.139466,"twenty":-2.734126,"median":-2.605757,"eighty":-2.530758,"high":-2.370297,"avg":-2.650669,"sd":0.185914,"marketCap":803286934},"quantilePoints":[{"date":"2026-02-06","current":-2.616222,"twenty":-3.034817,"median":-2.877844,"eighty":-2.720871,"marketCap":809765055},{"date":"2026-02-13","current":-2.586571,"twenty":-2.610292,"median":-2.537735,"eighty":-2.527619,"marketCap":800587717},{"date":"2026-02-20","current":-2.703429,"twenty":-2.7418,"median":-2.616222,"eighty":-2.529014,"marketCap":836757223},{"date":"2026-02-23","current":-2.595292,"twenty":-2.734126,"median":-2.605757,"eighty":-2.530758,"marketCap":803286934}],"updateTime":1771990311194},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EIKN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613894397","title":"Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2613894397","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613894397?lang=en_us&edition=fundamental","pubTime":"2026-02-23 19:54","pubTimestamp":1771847658,"startTime":"0","endTime":"0","summary":"UPDATE 3-Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPOAdds analyst comment in paragraphs 3,6,7By Arasu Kannagi BasilFeb 23 (Reuters) - Drug developer Generate Biomedicine","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL4N3ZJ0P5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875169.SGD","LU0345770308.USD","LU1791710582.SGD","BK4127","LU2471134523.USD","BK4534","LU0225283273.USD","IE0009355771.USD","LU2471134879.HKD","PIPR","BK4551","IE00BSNM7G36.USD","LU0048573561.USD","BK4548","AMGN","LU0795875086.SGD","LU1989772923.USD","LU2750360641.GBP","BK4568","LU1244550494.USD","IE00B2B36J28.USD","MANE","AGMB","BK4504","MRNX","GSX","LU0158827781.USD","AKTS","IE00BZ1G4Q59.USD","LU1868836914.USD","LU2112291526.USD","LU0158827948.USD","EIKN","LU1548497426.USD","LU2089284900.SGD","MRNY","SG9999001440.SGD","LU2242646821.SGD","LU0251142724.SGD","LU0320765646.SGD","LU0106261372.USD","LU0528227936.USD","LU1668664300.SGD","LU2028103732.USD","BK4566","SGP","LU1732800096.USD","MRNA","BK4148","LU2265009873.SGD"],"gpt_icon":0},{"id":"2610655654","title":"Wall Street Braces For IPO Boom: Goldman Says 2026 Listings Could Hit $160 Billion As Tech, AI Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2610655654","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610655654?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:30","pubTimestamp":1770643800,"startTime":"0","endTime":"0","summary":"The U.S. is reportedly poised for a wave of significant IPOs, with Goldman Sachs projecting proceeds to quadruple to a record $160 billion in 2026.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/09/Niles-Warns-Drawdown.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/09/Niles-Warns-Drawdown.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/ipos/26/02/50477465/wall-street-braces-for-ipo-boom-goldman-says-2026-listings-could-hit-160-billion-as-tech-ai-lead","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/ipos/26/02/50477465/wall-street-braces-for-ipo-boom-goldman-says-2026-listings-could-hit-160-billion-as-tech-ai-lead","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU1894683348.USD","LU2237443622.USD","LU1791807156.HKD","BK4533","LU1868837136.USD","LU0742534661.SGD","LU2237443465.HKD","LU0251142724.SGD","BK4552","LU0096364046.USD","LU0106831901.USD","BK4588","LU2471134879.HKD","LU1868837300.USD","LU1868836757.USD","LU2237443978.SGD","LU2237443382.USD","LU2471134952.CNY","LU2237443895.HKD","LU2471134796.USD","IE00BSNM7G36.USD","LU1894683264.USD","LU1868836591.USD","IE00BFXG1179.USD","LU2265009873.SGD","LU2750360997.AUD","LU1868836914.USD","LU2237443549.SGD","LU2471134523.USD","LU0061475181.USD","BK4504","BK4550","IE00B19Z3581.USD","BK4585","FPS","IE00B19Z3B42.SGD","LU0345770993.USD","LU1668664300.SGD","BK4127","LU0251131958.USD","LU2750360641.GBP","LU2237438978.USD","IE0004086264.USD","LU0345770308.USD","LU0048573561.USD","EIKN","IE0002270589.USD","IE0004091025.USD","LU1804176565.USD","GSX"],"gpt_icon":0},{"id":"2609543444","title":"Insiders Quietly Load Up on Eikon Therapeutics in Multi-Million Dollar Buying Spree","url":"https://stock-news.laohu8.com/highlight/detail?id=2609543444","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609543444?lang=en_us&edition=fundamental","pubTime":"2026-02-07 10:04","pubTimestamp":1770429865,"startTime":"0","endTime":"0","summary":"New insider activity at Eikon Therapeutics, Inc. ( ($EIKN) ) has taken place on February 6, 2026. Eikon Therapeutics, Inc. has seen a surge of insi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insiders-quietly-load-up-on-eikon-therapeutics-in-multi-million-dollar-buying-spree-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insiders-quietly-load-up-on-eikon-therapeutics-in-multi-million-dollar-buying-spree-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SHAP.U","EIKN"],"gpt_icon":0},{"id":"2609514399","title":"Eikon Therapeutics completes IPO and updates governance documents","url":"https://stock-news.laohu8.com/highlight/detail?id=2609514399","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609514399?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:30","pubTimestamp":1770413411,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics, Inc. ( ($EIKN) ) just unveiled an update. On February 6, 2026, Eikon Therapeutics, Inc. completed its initial public offering o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eikon-therapeutics-completes-ipo-and-updates-governance-documents?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eikon-therapeutics-completes-ipo-and-updates-governance-documents?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EIKN"],"gpt_icon":0},{"id":"2609258508","title":"Eikon Therapeutics Shares Fall in Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2609258508","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609258508?lang=en_us&edition=fundamental","pubTime":"2026-02-06 02:06","pubTimestamp":1770314799,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics  shares fell nearly 7% in recent trading on Thursday after its debut on the Nasdaq Stock Exchange.The stock fell to $16.81 in afternoon trading after the company priced an upsized initial public offering of 21.18 million shares at $18 each.The initial public offering is slated to close on Friday.Price: 16.68, Change: -1.32, Percent Change: -7.33","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NQmain","EIKN"],"gpt_icon":0},{"id":"1180668695","title":"Stock Track | Eikon Therapeutics Plummets 7.5% Intraday as Stock Debuts Below IPO Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1180668695","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180668695?lang=en_us&edition=fundamental","pubTime":"2026-02-06 02:04","pubTimestamp":1770314678,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics (EIKN) shares plummeted 7.50% intraday on Thursday, marking a challenging start for the clinical-stage biopharmaceutical company's public market debut.The decline came as the stock...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["EIKN"],"gpt_icon":0},{"id":"1169632829","title":"Eikon Therapeutics Debuts on Nasdaq with Over 5% Opening Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1169632829","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169632829?lang=en_us&edition=fundamental","pubTime":"2026-02-06 01:47","pubTimestamp":1770313654,"startTime":"0","endTime":"0","summary":"On Thursday, Eikon Therapeutics (EIKN.US) began trading on the Nasdaq exchange, opening more than 5% lower at $17.05 per share, below its IPO price of $18. The company was founded in 2019 by Nobel...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RWM","UWM","BK4535","BK1147","USJW.SI","GPIQ","JEPQ","NVIW.SI","TZA","TNA","BK4588","SRTY","QQQ","QQQY","TSYW.SI","QLD","BK4539","QQQM","QQQE","TWM","USAW.SI","BK4139","IWO","BK4585","PSQ","QYLD","QYLG","MNQmain","TQQQ","SQQQ","BK4581","QID","IWN","BK4550","BK4007","BK4534","QQQJ","EIKN"],"gpt_icon":1},{"id":"2609588092","title":"Eikon Therapeutics valued at $860 million in Nasdaq debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2609588092","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609588092?lang=en_us&edition=fundamental","pubTime":"2026-02-06 01:46","pubTimestamp":1770313564,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics valued at $860 million in Nasdaq debutFeb 5  - Shares of drug developer Eikon Therapeutics EIKN.O opened 5.28% below their offer price in their Nasdaq debut on Thursday, valuing the company at about $860.3 million.   ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nL4N3Z127P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EIKN"],"gpt_icon":0},{"id":"2609300485","title":"Eikon Therapeutics indicated to open at $17.92, IPO priced at $18 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2609300485","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609300485?lang=en_us&edition=fundamental","pubTime":"2026-02-06 00:45","pubTimestamp":1770309919,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics (EIKN) priced 21.18M shares at $18.00. The deal size was increased from 17.65M and priced at the top end of the $16.00-$18.00 ra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eikon-therapeutics-indicated-to-open-at-17-92-ipo-priced-at-18-per-share-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eikon-therapeutics-indicated-to-open-at-17-92-ipo-priced-at-18-per-share-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EIKN"],"gpt_icon":0},{"id":"1188370919","title":"Eikon Therapeutics Sets IPO Price at $18 Per Share, Raising $381.2 Million Ahead of Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1188370919","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188370919?lang=en_us&edition=fundamental","pubTime":"2026-02-05 15:22","pubTimestamp":1770276128,"startTime":"0","endTime":"0","summary":"Biopharmaceutical firm Eikon Therapeutics (EIKN.US) announced on Wednesday that its initial public offering in the United States has raised $381.2 million. The company issued approximately 21.2...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQE","QQQJ","BK4139","TQQQ","MNQmain","PSQ","USJW.SI","QYLG","BK4588","BK4007","EIKN","QYLD","QQQ","JEPQ","SQQQ","QQQM","USAW.SI","BK1147","NVIW.SI","GPIQ","TSYW.SI","QQQY","BK4585","BK4539","QID","QLD"],"gpt_icon":1},{"id":"2609348468","title":"Perlmutter-backed Eikon Therapeutics raises $381.2 million in IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2609348468","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609348468?lang=en_us&edition=fundamental","pubTime":"2026-02-05 09:29","pubTimestamp":1770254962,"startTime":"0","endTime":"0","summary":"UPDATE 1-Perlmutter-backed Eikon Therapeutics raises $381.2 million in IPOAdds details and context from paragraph 2Feb 4 (Reuters) - Drug developer Eikon Therapeutics said on Wednesday it had raised $","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nL4N3Z1041:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361045086.USD","LU0477156953.USD","LU1069347547.HKD","LU1699723380.USD","LU0203345920.USD","LU0256863811.USD","LU1941712348.USD","BK4516","LU0267386448.USD","IE00BZ1G4Q59.USD","LU0203347892.USD","LU2106854487.HKD","IE00B4R5TH58.HKD","LU2133065610.SGD","LU0477156797.USD","LU2125154935.USD","LU1201861165.SGD","LU1496350171.SGD","LU0158827948.USD","LU1201861249.SGD","SG9999001176.SGD","LU0106261372.USD","SG9999002232.USD","SG9999015358.SGD","LU0965509010.AUD","SG9999014559.SGD","SG9999014575.USD","BK4553","IE00BN8TJ469.HKD","LU0098860793.USD","LU2265009873.SGD","LU1066051225.USD","IE0001KFT4U8.USD","LU0321505439.SGD","LU0985320562.USD","IE00B7SZLL34.SGD","LU1791807156.HKD","LU2023250843.SGD","SG9999001176.USD","LU0557290698.USD","LU0882574139.USD","LU0861579265.USD","LU1023059063.AUD","LU0314106906.USD","LU1917777945.USD","LU1057294990.SGD","LU0320765646.SGD","SG9999015341.SGD","LU1061106388.HKD","LU1366192091.USD","LU0321505868.SGD","LU2112291526.USD","BK4581","LU0128525689.USD","LU0234572021.USD","LU1880398471.USD","LU1037948897.HKD","LU0149725797.USD","LU0265550359.USD","LU2089284900.SGD","LU0070302665.USD","LU1720051108.HKD","LU0130517989.USD","LU1506573853.SGD","LU2023251221.USD","LU0158827781.USD","LU1037948541.HKD","LU1363072403.SGD","LU1894683348.USD","LU0320765489.SGD","LU0432979614.USD","LU0795875169.SGD","LU2360032135.SGD","LU2271345857.HKD","BK4588","LU2023250504.SGD","LU0058720904.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","LU0795875086.SGD","LU0868494617.USD","LU0266013472.USD","LU0234570918.USD","LU1074936037.SGD","LU0683600562.USD","LU2129689431.USD","LU1244550494.USD","SG9999014542.SGD","LU1035773651.USD","BK4559","LU0225283273.USD","IE00B2B36J28.USD","LU2089283258.USD","LU2347655156.SGD","LU1066051498.USD","LU1720051017.SGD","SGXZ57979304.SGD","LU1791710582.SGD","LU1571399168.USD","LU0238689110.USD","LU0912757837.SGD","LU2357305700.SGD","SG9999001440.SGD","IE00B19Z3581.USD","LU1066051811.HKD","LU1116320737.USD","LU1066053197.SGD","LU0965509283.SGD","LU0170899867.USD","LU0289739699.SGD","LU1093756168.USD","BK4534","LU0965509101.SGD","LU2125154778.USD","LU1244550577.SGD","IE0002270589.USD","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","LU1934455277.USD","SG9999002224.SGD","LU1718418525.SGD","LU1941712264.USD","LU0980610538.SGD","LU1791710400.SGD","LU1894683264.USD","LU2461242641.AUD","BK4007","LU0265550946.USD","LU0256863902.USD","LU2361044865.SGD","LU1291159041.SGD","LU1430594728.SGD","LU1280957306.USD","LU2361044949.HKD","LU0787776722.HKD","LU0640476718.USD","LU0211331839.USD","LU0306806265.USD","LU0130102774.USD","LU1804176565.USD","IE00BKVL7J92.USD","LU0122379950.USD","LU1585245621.USD","LU1974910355.USD","SG9999014567.USD","LU1496350502.SGD","LU2468319806.SGD","LU2089984988.USD","BK4550","LU1883839398.USD","LU0106831901.USD","LU0965508806.USD","LU1989772923.USD","LU1929549753.HKD","IE0009355771.USD","LU0314104364.USD","LU0310800965.SGD","BK4207","LU1989772840.SGD","IE00BSNM7G36.USD","LU2129689514.USD","LU0053666078.USD","LU1162221912.USD","LU1668664300.SGD","LU1880398554.USD","IE0034235188.USD","LU1116320901.HKD","IE00BLSP4452.SGD","LU0006306889.USD","LU2324357040.USD","IE00B1BXHZ80.USD","LU0971096721.USD","LU1983299246.USD","BK4504","LU0528227936.USD","LU1244550221.USD","LU0052756011.USD","BK4127","LU1732800096.USD","LU2129689605.HKD","LU0648000940.SGD","LU2028103732.USD","LU1267930227.SGD","LU1989771016.USD","SG9999013999.USD","IE00B19Z3B42.SGD","BK4585","LU0648001328.SGD","LU0130103400.USD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1548497426.USD","LU1732799900.SGD","IE0002141913.USD","IE00BFXG1179.USD","LU0208291251.USD","EIKN","LU1934455194.USD","LU0417517546.SGD","LU2111349929.HKD","BK4533","LU0130518102.USD","LU0306807586.USD","IE00BFTCPJ56.SGD","LU1934455863.HKD"],"gpt_icon":0},{"id":"2609348152","title":"Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2609348152","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609348152?lang=en_us&edition=fundamental","pubTime":"2026-02-05 08:59","pubTimestamp":1770253140,"startTime":"0","endTime":"0","summary":"MILLBRAE, Calif., Feb.  04, 2026  (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing important, innovative medicines to add","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/05/3232603/0/en/Eikon-Therapeutics-Announces-Pricing-of-Upsized-Initial-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1363072403.SGD","BK4581","LU2089283258.USD","BK4504","LU1668664300.SGD","LU1989772840.SGD","EIKN","LU0098860793.USD","LU2271345857.HKD","LU1732800096.USD","LU1162221912.USD","BK4127","BK4534","LU0314104364.USD","LU1720051017.SGD","LU1548497426.USD","LU1244550577.SGD","LU0106261372.USD","IE00BKVL7J92.USD","LU2023251221.USD","LU0528227936.USD","LU0006306889.USD","LU2347655156.SGD","LU0234570918.USD","LU0158827948.USD","LU2111349929.HKD","LU1720051108.HKD","LU0557290698.USD","LU0795875086.SGD","LU2028103732.USD","LU1791710400.SGD","LU1732799900.SGD","LU1244550494.USD","LU0795875169.SGD","LU1791710582.SGD","LU0225283273.USD","LU1074936037.SGD","LU0267386448.USD","BK4516","LU1244550221.USD","LU0158827781.USD","BK4585","LU1989772923.USD","LU2089284900.SGD","LU0912757837.SGD","LU0106831901.USD","LU0882574139.USD","LU2133065610.SGD","LU0320765646.SGD","BK4588"],"gpt_icon":0},{"id":"2607037182","title":"Merck Expected to Buy $30 Million Stake in Eikon Therapeutics' IPO, Bloomberg Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2607037182","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607037182?lang=en_us&edition=fundamental","pubTime":"2026-01-30 01:33","pubTimestamp":1769708022,"startTime":"0","endTime":"0","summary":"Price: 108.93, Change: +2.03, Percent Change: +1.90","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009355771.USD","LU0965508806.USD","LU1989772923.USD","LU1066053197.SGD","IE0002141913.USD","IE00B2B36J28.USD","SG9999001176.SGD","EIKN","LU1116320901.HKD","IE00BLSP4239.USD","LU2125154935.USD","LU0203345920.USD","SG9999013999.USD","SGXZ57979304.SGD","BK4534","LU2361044865.SGD","LU1037948541.HKD","SG9999014575.USD","LU0208291251.USD","LU0432979614.USD","LU1023059063.AUD","SG9999015358.SGD","LU0477156953.USD","LU1069347547.HKD","LU2360032135.SGD","LU0234572021.USD","IE00B1BXHZ80.USD","SG9999014559.SGD","LU0265550359.USD","LU0861579265.USD","LU1066051225.USD","IE00BLSP4452.SGD","LU0098860793.USD","LU1571399168.USD","SG9999014542.SGD","LU1974910355.USD","LU2023250843.SGD","IE00BJJMRZ35.SGD","LU1116320737.USD","LU1066051811.HKD","SG9999001176.USD","LU0648001328.SGD","LU1035773651.USD","IE00BBT3K403.USD","LU2361045086.USD","BK4585","LU1941712348.USD","LU1093756325.SGD","IE00BSNM7G36.USD","LU1585245621.USD","LU0006306889.USD","BK4516","LU0058720904.USD","LU1066051498.USD","LU1917777945.USD","LU0130102774.USD","LU0122379950.USD","LU0965509283.SGD","LU1699723380.USD","LU0320765489.SGD","LU0211331839.USD","LU1037948897.HKD","LU2106854487.HKD","LU0980610538.SGD","LU1941712264.USD","IE00B4R5TH58.HKD","SG9999002224.SGD","BK4550","LU0320765646.SGD","LU1061106388.HKD","SG9999002232.USD","LU1983299246.USD","LU2089984988.USD","LU0238689110.USD","LU0265550946.USD","LU0965509010.AUD","LU0985320562.USD","LU1162221912.USD","IE00BJT1NW94.SGD","LU1430594728.SGD","LU2125154778.USD","LU1093756168.USD","SG9999015341.SGD","LU2468319806.SGD","BK4533","SG9999014567.USD","BK4588","LU1929549753.HKD","LU1291159041.SGD","IE000M9KFDE8.USD","LU1934455194.USD","MRK","LU1934455277.USD","LU2023250504.SGD","LU0289739699.SGD","LU0266013472.USD","BK4559","LU1989771016.USD","LU2461242641.AUD","LU1201861249.SGD","LU0965509101.SGD","LU1934455863.HKD","LU2361044949.HKD","IE00BFTCPJ56.SGD","LU0070302665.USD","IE00BN8TJ469.HKD","LU0203347892.USD","LU1057294990.SGD","LU2112291526.USD","LU0106261372.USD","LU1989772840.SGD","BK4007","SG9999001440.SGD","LU0130517989.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"1196766409","title":"Merck Veteran Executives Lead Cancer Drug Developer Eikon Therapeutics (EIKN.US) in US IPO Push","url":"https://stock-news.laohu8.com/highlight/detail?id=1196766409","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196766409?lang=en_us&edition=fundamental","pubTime":"2026-01-10 15:07","pubTimestamp":1768028868,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics (EIKN.US), a company focused on cancer drug research and development, has officially filed for an initial public offering in the United States, aiming to secure funding for its...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU1069347547.HKD","LU1291159041.SGD","LU0648001328.SGD","SG9999013999.USD","LU1941712264.USD","LU0203347892.USD","LU1430594728.SGD","SG9999002224.SGD","SGXZ57979304.SGD","BK4588","LU0203345920.USD","SG9999001440.SGD","LU0006306889.USD","LU1917777945.USD","LU1585245621.USD","LU1934455863.HKD","SG9999001176.USD","LU1934455194.USD","SG9999014559.SGD","EIKN","LU0861579265.USD","LU2361044865.SGD","LU0477156953.USD","SG9999001176.SGD","IE00BSNM7G36.USD","LU0122379950.USD","LU1061106388.HKD","SG9999015341.SGD","BK4139","LU2324357040.USD","LU2361044949.HKD","IE00BJT1NW94.SGD","LU1974910355.USD","IE00BLSP4239.USD","LU1116320737.USD","IE00B1BXHZ80.USD","LU0130102774.USD","LU1093756325.SGD","LU0058720904.USD","IE00B4R5TH58.HKD","LU0320765646.SGD","BK4539","LU0106261372.USD","LU0211331839.USD","IE00BLSP4452.SGD","LU1037948541.HKD","IE00BN8TJ469.HKD","LU2125154935.USD","LU0965509283.SGD","LU0208291251.USD","LU1023059063.AUD","BK4550","IE0002141913.USD","LU1057294990.SGD","BK4533","LU1035773651.USD","LU0980610538.SGD","LU2023250504.SGD","LU0130517989.USD","LU0265550359.USD","IE0009355771.USD","LU1162221912.USD","LU1989771016.USD","LU2360032135.SGD","LU2468319806.SGD","LU0098860793.USD","SG9999015358.SGD","LU0965509101.SGD","LU1571399168.USD","LU1116320901.HKD","BK4516","IE00B2B36J28.USD","LU2112291526.USD","LU1037948897.HKD","LU2125154778.USD","LU0289739699.SGD","LU0070302665.USD","BK4559","LU1929549753.HKD","LU1934455277.USD","LU0266013472.USD","SG9999014575.USD","LU0965509010.AUD","LU0320765489.SGD","LU1699723380.USD","LU1093756168.USD","LU2089984988.USD","BK4534","SG9999002232.USD","IE00BBT3K403.USD","LU2461242641.AUD","LU1066051498.USD","LU2106854487.HKD","SG9999014542.SGD","LU2361045086.USD","LU0238689110.USD","LU1989772923.USD","LU0985320562.USD","LU0265550946.USD","BK4007","LU1066051811.HKD","LU1201861249.SGD","IE00BFTCPJ56.SGD","LU2023250843.SGD","LU1066053197.SGD","LU0965508806.USD","IE00BJJMRZ35.SGD","SG9999014567.USD","LU1983299246.USD","BK4585","LU1066051225.USD","LU0234572021.USD","LU1989772840.SGD","LU1941712348.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}